S1 Ep4: What You Need To Know About The Evolving Role Of TIL Therapy In Cancer Treatment PER Spectives podcast

Artwork

Science Biology Podcasting Education Medicine Spectives

Indhold leveret af PER Spectives and PER® Spectives. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af PER Spectives and PER® Spectives eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

PER Spectives « »
S1 Ep4: What You Need to Know About the Evolving Role of TIL Therapy in Cancer Treatment

2y ago 23:04

Del

MP3•Episode hjem

Indhold leveret af PER Spectives and PER® Spectives. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af PER Spectives and PER® Spectives eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

Tumor-infiltrating lymphocyte (TIL) is an emerging therapy that may one day change the approach to the management of solid tumors including melanoma, NSCLC, and more. Join us for a conversation with Dr. Omid Hamid, one of the principal investigators pioneering TIL therapy in clinical trials, as we discuss this novel treatment method. Dr. Hamid will break down what the community physician needs to know about this emerging therapy as it makes it’s way out of clinical trials and into the clinic.

Featuring:
Omid Hamid, MD
Cedars-Sinai CANCER
Los Angeles, CA

… continue reading

27 episoder

#Science #Biology #Podcasting Education #Medicine #Spectives

Artwork

S1 Ep4: What You Need to Know About the Evolving Role of TIL Therapy in Cancer Treatment

published 2y ago

Del

MP3•Episode hjem

Indhold leveret af PER Spectives and PER® Spectives. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af PER Spectives and PER® Spectives eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

Tumor-infiltrating lymphocyte (TIL) is an emerging therapy that may one day change the approach to the management of solid tumors including melanoma, NSCLC, and more. Join us for a conversation with Dr. Omid Hamid, one of the principal investigators pioneering TIL therapy in clinical trials, as we discuss this novel treatment method. Dr. Hamid will break down what the community physician needs to know about this emerging therapy as it makes it’s way out of clinical trials and into the clinic.

Featuring:
Omid Hamid, MD
Cedars-Sinai CANCER
Los Angeles, CA

… continue reading

27 episoder

#Science #Biology #Podcasting Education #Medicine #Spectives

Alle episoder

×

Velkommen til Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

Lyt til 500+ emner